Main > ONCOLOGY (**) > Leukemia>Myeloid>Chronic>CP > TREAT.: > CN. A. 3G BCR-ABL Inhibitor

---

CN. A. 3G BCR-ABL Inhibitor's subsections
(*) CN Approval Date: 2023. 11.17
(*) CN Launch Date: 2023. 11.24
Company
Generic Name
Patent>CN Patent Number
TM

CN. A. 3G BCR-ABL Inhibitor's products
This section has no products